Vittoria Biotherapeutics
PrivateLast Round
Private Financing
Extension
Nov 12, 2024
Total Funding Raised
$35M
Company Overview
Vittoria Biotherapeutics is a biotechnology company developing novel CAR T-cell therapies that transcend the limitations of current cell therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vittoria Biotherapeutics Comparables
Compare Vittoria Biotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| March Biosciences | 89% | |
| Wugen | 83% | |
| Mustang Bio Inc | 78% | |
Vittoria Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Financing Extension | Nov 12, 2024 | ||||
| Series A | Nov 14, 2023 | ||||
| Seed | Jun 7, 2022 |
Key People
Founding team and executive leadership
Vittoria Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Agent Capital | Private Financing Extension, Seed, Series A |
| University of Pennsylvania Office of Investments | Private Financing Extension, Series A |
| RM Global Partners | Private Financing Extension |
| Tellus BioVentures | Private Financing Extension, Seed, Series A |
| Valley Forge Investment Corporation | Private Financing Extension, Series A |
| The Leukemia & Lymphoma Society (LLS) Therapy Acceleration Program (TAP) | Series A |
| BioAdvance Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 3, 2025
Attended the 10th annual Penn Center for Innovation's Celebration of Innovation.
- Dec 3, 2025
Recognized for advancements in cellular therapy for T-cell lymphoma.
Vittoria Biotherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vittoria Biotherapeutics's valuation, stock price, and market status.